- Home
- ATRA vs WLGS Comparison
ATRA vs WLGS Comparison
Compare ATRA & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- WLGS
- Stock Information
- Founded
- ATRA 2012
- WLGS 1981
- Country
- ATRA United States
- WLGS Hong Kong
- Employees
- ATRA N/A
- WLGS N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- WLGS Engineering & Construction
- Sector
- ATRA Health Care
- WLGS Consumer Discretionary
- Exchange
- ATRA Nasdaq
- WLGS Nasdaq
- Market Cap
- ATRA 50.3M
- WLGS 54.6M
- IPO Year
- ATRA 2014
- WLGS 2023
- Fundamental
- Price
- ATRA $11.47
- WLGS $4.44
- Analyst Decision
- ATRA Hold
- WLGS
- Analyst Count
- ATRA 5
- WLGS 0
- Target Price
- ATRA $26.88
- WLGS N/A
- AVG Volume (30 Days)
- ATRA 143.0K
- WLGS 82.5K
- Earning Date
- ATRA 11-12-2024
- WLGS 12-03-2024
- Dividend Yield
- ATRA N/A
- WLGS N/A
- EPS Growth
- ATRA N/A
- WLGS N/A
- EPS
- ATRA N/A
- WLGS N/A
- Revenue
- ATRA $100,439,000.00
- WLGS $6,825,879.00
- Revenue This Year
- ATRA $1,190.80
- WLGS N/A
- Revenue Next Year
- ATRA N/A
- WLGS N/A
- P/E Ratio
- ATRA N/A
- WLGS N/A
- Revenue Growth
- ATRA 2111.34
- WLGS 63.69
- 52 Week Low
- ATRA $6.50
- WLGS $0.44
- 52 Week High
- ATRA $39.50
- WLGS $5.00
- Technical
- Relative Strength Index (RSI)
- ATRA 55.91
- WLGS 63.71
- Support Level
- ATRA $10.03
- WLGS $3.51
- Resistance Level
- ATRA $14.93
- WLGS $4.30
- Average True Range (ATR)
- ATRA 1.38
- WLGS 0.69
- MACD
- ATRA -0.13
- WLGS -0.01
- Stochastic Oscillator
- ATRA 39.51
- WLGS 75.11
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.